Beta Bionics (BBNX) Gross Margin (2024 - 2026)

Beta Bionics' Gross Margin history runs 3 years deep, the most recent figure standing at 59.5% for Q1 2026.

• In Q1 2026, Gross Margin rose 864.0% year-over-year to 59.5%; the TTM figure through Mar 2026 stood at 57.15% (up 322.0% YoY), while the FY2025 annual figure was 55.4%, up 29.0% from the prior year.
• Gross Margin came in at 59.5% for Q1 2026 at Beta Bionics, up from 58.98% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 59.5% in Q1 2026 to a low of 50.86% in Q1 2025.
• A 3-year average of 55.4% and a median of 55.48% in 2025 frame the typical range for Gross Margin.
• Across the five-year window, Gross Margin tumbled 482 bps in 2025 and jumped 864 bps in 2026, its largest moves.
• Beta Bionics' Gross Margin stood at 57.19% in 2024, then grew by 3 bps to 58.98% in 2025, then gained by 1 bps to 59.5% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 59.5%, 58.98%, and 55.48% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison